AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

A Pro-Apoptotic Microbial Community Network is Enriched in the Tissue of IPF and Lung Cancer Patients

Detailed Technology Description: Dr. Isaac Cann from the University of Illinois has identified biomarkers and therapeutic strategy for treatment of idiopathic pulmonary fibrosis (IPF) and lung cancer.

Countries: Not Available

Application No.: None

*Abstract: Dr. Isaac Cann from the University of Illinois has identified biomarkers and therapeutic strategy for treatment of idiopathic pulmonary fibrosis (IPF) and lung cancer. This strategy has the potential to dramatically improve the lives of millions patients throughout the world. It is the first know effective treatment route for IPF. The therapeutic strategy is based on the discovery of link between microbial community remodeling and IPF. Furthermore, the lung microbial community can induce excessive apoptosis of alveolar lining epithelial cells leading to lung carcinogenesis.

*IP Issue Date: None

*IP Type: Other Patent

Country/Region: USA

For more information, please click Here